Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Assessing Surveillance Case Definitions for Zika Virus

Published: Mon, 26 Jun 2017 12:00:00 EDT
How useful are surveillance case definitions for detecting Zika virus disease?
Emerging Infectious Diseases

Monotherapy With Biologic DMARDs in Rheumatoid Arthritis

Published: Mon, 26 Jun 2017 12:00:00 EDT
Biologic DMARD monotherapy may be a viable treatment alternative for patients with rheumatoid arthritis when combination therapy is not an option.

Acute Pain Management for Patients on Chronic Buprenorphine

Published: Mon, 26 Jun 2017 12:00:00 EDT
The treatment of perioperative pain in patients taking buprenorphine for opioid maintenance therapy is challenging. What are the options?

Is it Fat or Lean That Ultimately Determines AF Risk?

Published: Mon, 26 Jun 2017 12:00:00 EDT
A new study suggests that lean body mass is the predominant anthropometric risk factor for atrial fibrillation, but the relationship may not be so black-and-white, according to this commentary.
Journal of the American College of Cardiology
Displaying results 13-16 (of 20)
 1 - 2 - 3 - 4 - 5 


Clinigen makes 3 exclusive compassionate-use deals

Published: Wed, 21 Jun 2017 14:38:52 +0000
Clinigen has signed exclusive agreements with Mitsubishi Tanabe, Shionogi and Romark to cooperate on expanded access to their medicines.

Vineti scores $13M+, launches cloud-based platform for cell therapies

Published: Wed, 21 Jun 2017 13:16:28 +0000
With the first CAR-T treatments poised to hit the market this year, the companies making them must scale up their manufacturing to meet demand. Enter Vineti, which is launching its end-to-end, cloud-based system to streamline company processes and accelerate patient access to these therapies.

Sarepta signs another Duchenne gene therapy pact as it aims for wider treatment

Published: Wed, 21 Jun 2017 12:46:48 +0000
Sarepta Therapeutics has penned its second DMD gene therapy pact this year as it announces a tie-up with France’s Genethon, a nonprofit R&D org.

Cash-strapped ImmunoCellular halts brain cancer vaccine trial, eyes 'strategic alternatives'

Published: Wed, 21 Jun 2017 11:34:31 +0000
ImmunoCellular Therapeutics has been forced to suspend a phase 3 trial of its lead cancer vaccine, ICT-107, after failing to raise the funds it needs to complete the study.
Displaying results 13-16 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy